Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The company offers laboratory instruments, such as laboratory balances, liquid pipetting solutions, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, density and refractometry instruments, and thermal analysis systems; and other analytical instruments, including UV/VIS spectrophotometers, moisture analyzers, and cell counters, as well as LabX, a laboratory software platform to manage and analyze data generated by its instruments and automate workflows. It also provides industrial instruments comprising industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detectors, x-ray systems, checkweighers, and camera-based imaging equipment. In addition, the company offers retail weighing solutions consisting of weighing and software solutions, AI-driven image recognition solutions for fresh goods, and automated packaging and labeling solutions for the meat backroom. The company serves pharmaceutical and biotech companies, independent research organizations, and testing labs; food manufacturers and retailers; chemical, specialty chemicals, and cosmetics companies; transportation and logistics, metals, and electronics industries; and academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is headquartered in Greifensee, Switzerland.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $4.0B | $1.2B | $869M | $849M | -3677.4% | 4.0% | 0.7% |
| 2024 | $3.9B | $1.2B | $863M | $864M | -680.2% | 2.2% | 9.4% |
| 2023 | $3.8B | $1.2B | $789M | $861M | -526.1% | -3.4% | -9.6% |
| 2022 | $3.9B | $1.2B | $873M | $738M | 3519.1% | - | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total Revenue | 3,919.71 | 3,788.31 | 3,872.36 | 4,026.40 |
| Cost Of Revenue | 1,611.67 | 1,547.02 | 1,546.78 | 1,635.75 |
| Gross Profit | 2,308.04 | 2,241.29 | 2,325.58 | 2,390.65 |
| Operating Expense | 1,181.82 | 1,161.60 | 1,198.53 | 1,272.16 |
| Operating Income | 1,126.22 | 1,079.68 | 1,127.05 | 1,118.49 |
| EBITDA | 1,239.01 | 1,172.26 | 1,235.08 | 1,243.03 |
| EBIT | 1,125.98 | 1,051.09 | 1,111.85 | 1,117.42 |
| Pretax Income | 1,070.59 | 973.73 | 1,037.22 | 1,048.91 |
| Tax Provision | 198.09 | 184.95 | 174.08 | 179.72 |
| Net Income | 872.50 | 788.78 | 863.14 | 869.19 |
| Net Income Common Stockholders | 872.50 | 788.78 | 863.14 | 869.19 |
| Total Expenses | 2,793.49 | 2,708.63 | 2,745.31 | 2,907.91 |
| Interest Expense | 55.39 | 77.37 | 74.63 | 68.52 |
| Research And Development | 177.12 | 185.28 | 189.36 | 199.37 |
| Selling General And Administration | 938.46 | 904.11 | 936.30 | 998.31 |
| Normalized EBITDA | 1,248.56 | 1,204.99 | 1,254.85 | 1,260.90 |
| Normalized Income | 880.29 | 815.29 | 879.55 | 884.01 |
| Market Cap | 25,967.69 | 25,967.69 | 25,967.69 | 25,967.69 |
Healthcare sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| Mettler-Toledo International Inc.this co. | MTD | $26.4B | 29.88β premium | -1098.65 | -3677.4% | 22.57 |
| IQVIA Holdings Inc. | IQV | $27.9B | 20.03 | 4.19 | 20.9% | 11.90 |
| Biogen Inc. | BIIB | $27.0B | 20.93 | 1.48 | 7.1% | 11.76 |
| Humana Inc. | HUM | $25.9B | 21.75 | 1.46 | 6.7% | - |
| DexCom, Inc. | DXCM | $24.0B |
| 28.41 |
| 8.65 |
| 30.5% |
| 17.84 |
| West Pharmaceutical Services, Inc. | WST | $22.1B | 43.81 | 6.81 | 15.5% | 27.38 |
| Quest Diagnostics Incorporated | DGX | $21.9B | 21.90 | 3.03 | 13.8% | 12.88 |
| Labcorp Holdings Inc. | LH | $21.9B | 24.80 | 2.52 | 10.2% | 13.78 |
| STERIS plc | STE | $21.8B | 35.42 | 3.30 | 9.3% | 17.52 |
| Peer Median | - | 23.35 | 3.16 | 12.0% | 13.78 | |